Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 6,941–6,960 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

Viatrexx-Male+, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0400, NDC 73069-320-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Neuro, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0460, NDC 73069-375-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Hair, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0251, NDC 73069-206-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Facial, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0184, NDC 73069-164-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Intra-Cell, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0280, NDC 73069-250-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Relief +, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0615, NDC 73069-450-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Immunexx, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0270, NDC 73069-244-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Arthros, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0030, NDC 73069-035-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-GI, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0211, NDC 73069-189-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Mesenchyme, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0092, NDC 73069-102-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Lymph 1, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0370, NDC 73069-310-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Prolo, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0558, NDC 73069-443-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Collagen, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0085, NDC 73069-095-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Infla, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0279, NDC 73069-249-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Neuro 3, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0463, NDC 73069-373-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Articula, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0031, NDC 73069-037-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Systemic Detox, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0665, NDC 73069-500-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Adipose, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0008, NDC 73069-024-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Ithurts, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0290, NDC 73069-270-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Viatrexx-Ouch, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0500, NDC 73069-402-41.

by 8046255 Canada Inc. DBA Viatrexx

Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Recall initiated
October 15, 2019
Reported by FDA
November 20, 2019
Distribution
Distributed to physicians Nationwide throughout the United States and Puerto Rico.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.